Evidence map›Paper›PMID 33120969›Full record

ArticleInternational journal of molecular sciences2020

Survival of Lung Cancer Patients Dependent on the LOH Status for

Elizabeth A Fry, Gloria E Niehans, Robert A Kratzke, Fumitake Kai, Kazushi Inoue

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Elizabeth A FryDept. of Pathology, Wake Forest University School of Medicine, Medical Center Blvd., Winston-Salem, NC 27157, USA.
Gloria E NiehansMinneapolis VA Medical Center, Minneapolis, MN 55417, USA.
Robert A KratzkeDept. of Medicine, University of Minnesota Medical Center, Masonic Cancer Institute, Minneapolis, MN 55455, USA.ORCID 0000-0002-1599-7494
Fumitake KaiDept. of Pathology, Wake Forest University School of Medicine, Medical Center Blvd., Winston-Salem, NC 27157, USA.
Kazushi InoueDept. of Pathology, Wake Forest University School of Medicine, Medical Center Blvd., Winston-Salem, NC 27157, USA.
Wake Forest University · USMinneapolis VA Medical Center · USUniversity of Minnesota Medical Center · US

Funding

American Cancer Society RSG-07-207-01-MGONIH HHS 106314Susan G. Komen for the Cure KG080179
6 · The paper itself

Abstract

Lung cancer is the leading cause of cancer deaths in the world, and accounts for more solid tumor deaths than any other carcinomas. The prognostic values of

Indexed as

Carcinoma, Non-Small-Cell LungCyclin-Dependent Kinase Inhibitor p16FemaleHumansLoss of HeterozygosityLung NeoplasmsMalePrognosisSurvival AnalysisTranscription FactorsTumor Suppressor Protein p53CDKN2A protein, humanCyclin-Dependent Kinase Inhibitor p16DMTF1 protein, humanTP53 protein, humanTranscription FactorsTumor Suppressor Protein p53ARFCyclin D1DMTF1INK4ap53YY1

Identifiers

PMID33120969
PMCPMC7662351
OpenAlexW3097529338

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.